GILD—England will pay for ~500 HCV patients suffering from liver failure to be treated with Sovaldi in advance of a general reimbursement ruling by NICE:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.